Status of adult inpatient burn rehabilitation in Europe: Are we neglecting metabolic outcomes?

Adults Burn care Burn rehabilitation Early mobilization Exercise Hypermetabolism

Journal

Burns & trauma
ISSN: 2321-3868
Titre abrégé: Burns Trauma
Pays: England
ID NLM: 101651457

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 15 04 2020
revised: 10 06 2020
entrez: 12 3 2021
pubmed: 13 3 2021
medline: 13 3 2021
Statut: epublish

Résumé

Hypermetabolism, muscle wasting and insulin resistance are challenging yet important rehabilitation targets in the management of burns. In the absence of concrete practice guidelines, however, it remains unclear how these metabolic targets are currently managed. This study aimed to describe the current practice of inpatient rehabilitation across Europe. An electronic survey was distributed by the European Burn Association to burn centres throughout Europe, comprising generic and profession-specific questions directed at therapists, medical doctors and dieticians. Questions concerned exercise prescription, metabolic management and treatment priorities, motivation and knowledge of burn-induced metabolic sequelae. Odds ratios were computed to analyse associations between data derived from the responses of treatment priorities and knowledge of burn-induced metabolic sequelae. Fifty-nine clinicians with 12.3 ± 9 years of professional experience in burns, representing 18 out of 91 burn centres (response rate, 19.8%) across eight European countries responded. Resistance and aerobic exercises were only provided by 42% and 38% of therapists to intubated patients, 87% and 65% once out-of-bed mobility was possible and 97% and 83% once patients were able to leave their hospital room, respectively. The assessment of resting energy expenditure by indirect calorimetry, muscle wasting and insulin resistance was carried out by only 40.7%, 15.3% and 7.4% respondents, respectively, with large variability in employed frequency and methods. Not all clinicians changed their care in cases of hypermetabolism (59.3%), muscle wasting (70.4%) or insulin resistance (44.4%), and large variations in management strategies were reported. Significant interdisciplinary variation was present in treatment goal importance ratings, motivation and knowledge of burn-induced metabolic sequelae. The prevention of metabolic sequelae was regarded as the least important treatment goal, while the restoration of functional status was rated as the most important. Knowledge of burn-induced metabolic sequelae was linked to higher importance ratings of metabolic sequelae as a therapy goal (odds ratio, 4.63; 95% CI, 1.50-14.25; This survey reveals considerable non-uniformity around multiple aspects of inpatient rehabilitation across European burn care, including, most notably, a potential neglect of metabolic outcomes. The results contribute to the necessary groundwork to formulate practice guidelines for inpatient burn rehabilitation.

Sections du résumé

BACKGROUND BACKGROUND
Hypermetabolism, muscle wasting and insulin resistance are challenging yet important rehabilitation targets in the management of burns. In the absence of concrete practice guidelines, however, it remains unclear how these metabolic targets are currently managed. This study aimed to describe the current practice of inpatient rehabilitation across Europe.
METHODS METHODS
An electronic survey was distributed by the European Burn Association to burn centres throughout Europe, comprising generic and profession-specific questions directed at therapists, medical doctors and dieticians. Questions concerned exercise prescription, metabolic management and treatment priorities, motivation and knowledge of burn-induced metabolic sequelae. Odds ratios were computed to analyse associations between data derived from the responses of treatment priorities and knowledge of burn-induced metabolic sequelae.
RESULTS RESULTS
Fifty-nine clinicians with 12.3 ± 9 years of professional experience in burns, representing 18 out of 91 burn centres (response rate, 19.8%) across eight European countries responded. Resistance and aerobic exercises were only provided by 42% and 38% of therapists to intubated patients, 87% and 65% once out-of-bed mobility was possible and 97% and 83% once patients were able to leave their hospital room, respectively. The assessment of resting energy expenditure by indirect calorimetry, muscle wasting and insulin resistance was carried out by only 40.7%, 15.3% and 7.4% respondents, respectively, with large variability in employed frequency and methods. Not all clinicians changed their care in cases of hypermetabolism (59.3%), muscle wasting (70.4%) or insulin resistance (44.4%), and large variations in management strategies were reported. Significant interdisciplinary variation was present in treatment goal importance ratings, motivation and knowledge of burn-induced metabolic sequelae. The prevention of metabolic sequelae was regarded as the least important treatment goal, while the restoration of functional status was rated as the most important. Knowledge of burn-induced metabolic sequelae was linked to higher importance ratings of metabolic sequelae as a therapy goal (odds ratio, 4.63; 95% CI, 1.50-14.25;
CONCLUSION CONCLUSIONS
This survey reveals considerable non-uniformity around multiple aspects of inpatient rehabilitation across European burn care, including, most notably, a potential neglect of metabolic outcomes. The results contribute to the necessary groundwork to formulate practice guidelines for inpatient burn rehabilitation.

Identifiants

pubmed: 33709001
doi: 10.1093/burnst/tkaa039
pii: tkaa039
pmc: PMC7935379
doi:

Types de publication

Journal Article

Langues

eng

Pagination

tkaa039

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press.

Références

J Burn Care Res. 2017 Jan/Feb;38(1):e261-e268
pubmed: 27359189
Ann Intensive Care. 2017 Dec;7(1):40
pubmed: 28382599
Clin Rehabil. 2015 Nov;29(11):1051-63
pubmed: 25681407
Burns. 2016 Mar;42(2):366-74
pubmed: 26777451
Clin Plast Surg. 2017 Oct;44(4):729-735
pubmed: 28888298
Intensive Care Med. 2014 Apr;40(4):548-55
pubmed: 24477456
Diabetes Care. 2000 Jan;23(1):57-63
pubmed: 10857969
Am J Physiol Endocrinol Metab. 2018 Mar 1;314(3):E232-E240
pubmed: 29138224
Burns. 2007 Jun;33(4):429-34
pubmed: 17466461
Exerc Sport Sci Rev. 2015 Jan;43(1):34-40
pubmed: 25390300
J Burn Care Res. 2019 Jan 1;40(1):29-33
pubmed: 30351404
Crit Care Med. 2016 Jun;44(6):1059-66
pubmed: 26934145
J Cachexia Sarcopenia Muscle. 2017 Oct;8(5):713-726
pubmed: 28722298
Eur J Clin Nutr. 2019 Feb;73(2):187-193
pubmed: 30377307
J Appl Physiol (1985). 2001 Sep;91(3):1168-75
pubmed: 11509512
Sci Rep. 2016 Oct 03;6:34650
pubmed: 27694999
J Burn Care Res. 2016 Nov/Dec;37(6):e539-e558
pubmed: 26284636
Scand J Surg. 2019 Dec;108(4):297-304
pubmed: 30474468
BMJ Open. 2019 Feb 15;9(2):e025135
pubmed: 30772859
Eur J Clin Nutr. 2018 Jul;72(7):1019-1025
pubmed: 29748659
Nephrol Dial Transplant. 1998 Mar;13(3):685-99
pubmed: 9550648
Burns. 2012 May;38(3):348-55
pubmed: 22040931
Int J Environ Res Public Health. 2019 Jan 07;16(1):
pubmed: 30621076
Rev Endocr Metab Disord. 2016 Mar;17(1):81-90
pubmed: 27106830
Burns. 2016 Mar;42(2):267-75
pubmed: 26787131
JPEN J Parenter Enteral Nutr. 2010 Jan-Feb;34(1):55-63
pubmed: 19884353
Burns. 2016 Aug;42(5):953-1021
pubmed: 27542292
Crit Care Med. 2002 Nov;30(11):2438-42
pubmed: 12441751
J Burn Care Res. 2010 May-Jun;31(3):400-8
pubmed: 20354445
Burns. 2018 May;44(3):566-572
pubmed: 29306596
Crit Care Med. 2013 Jun;41(6):1543-54
pubmed: 23528802
Burns. 2013 Mar;39(2):269-78
pubmed: 22981799
J Crit Care. 2017 Apr;38:137-143
pubmed: 27902947
Ann Surg. 2018 Mar;267(3):576-584
pubmed: 29408836
J Burn Care Res. 2013 Nov-Dec;34(6):e311-7
pubmed: 23511288
Burns. 2020 Mar;46(2):322-332
pubmed: 31864784
PLoS One. 2011;6(7):e21245
pubmed: 21789167
J Clin Endocrinol Metab. 2009 May;94(5):1656-64
pubmed: 19240154
Burns. 2016 Nov;42(7):1404-1412
pubmed: 27595451
J Crit Care. 2015 Oct;30(5):1151.e9-14
pubmed: 26211979
Lancet. 2016 Oct 1;388(10052):1417-1426
pubmed: 27707498
Surgery. 2000 Aug;128(2):312-9
pubmed: 10923010
J Burn Care Res. 2011 Mar-Apr;32(2):210-23
pubmed: 21240002
Burns. 2009 Feb;35(1):63-9
pubmed: 18672331
Burns. 2014 Feb;40(1):54-60
pubmed: 23831170
J Burn Care Res. 2012 May-Jun;33(3):319-29
pubmed: 21959211
Intensive Care Med. 2017 Feb;43(2):171-183
pubmed: 27864615
Crit Care. 2018 Apr 27;22(1):110
pubmed: 29703223
JPEN J Parenter Enteral Nutr. 2017 Sep;41(7):1131-1138
pubmed: 27221673
Burns. 2018 Jun;44(4):731-751
pubmed: 29017743
Clin Nutr. 2013 Aug;32(4):497-502
pubmed: 23582468
Injury. 2016 Sep;47(9):1975-82
pubmed: 27085837
Clin Nutr. 2020 Jun;39(6):1809-1817
pubmed: 31492456
Cochrane Database Syst Rev. 2014 Jan 30;(1):CD006832
pubmed: 24477672
J Burn Care Res. 2018 Oct 23;39(6):897-901
pubmed: 29579311
Burns. 2017 Mar;43(2):249-257
pubmed: 27600982
Burns Trauma. 2018 Jan 17;6:3
pubmed: 30009191
Chest. 2014 Sep;146(3):583-589
pubmed: 25180722
Intensive Care Med. 2016 Sep;42(9):1445-53
pubmed: 27515162
Clin Rehabil. 2018 Jun;32(6):734-746
pubmed: 29320878
Clin Nutr. 2019 Dec;38(6):2747-2755
pubmed: 30612851
J Burn Care Rehabil. 1992 Nov-Dec;13(6):656-62
pubmed: 1469031
J Burn Care Res. 2014 Jul-Aug;35(4):e234-9
pubmed: 24419142
JAMA. 2013 Oct 16;310(15):1591-600
pubmed: 24108501
J Appl Physiol (1985). 2015 Jun 15;118(12):1474-82
pubmed: 25882384
Intensive Care Med. 2019 Dec;45(12):1718-1731
pubmed: 31531715
J Intensive Care. 2018 Dec 12;6:81
pubmed: 30564367
Burns. 2016 Dec;42(8):1734-1739
pubmed: 27338180
JPEN J Parenter Enteral Nutr. 2006 Jul-Aug;30(4):331-8
pubmed: 16804131
Crit Care Med. 2015 Apr;43(4):897-905
pubmed: 25559437
Phys Ther. 2013 Feb;93(2):186-96
pubmed: 22879442
J Burn Care Res. 2009 Mar-Apr;30(2):281-7
pubmed: 19165113
Ann Surg. 2002 Jan;235(1):152-61
pubmed: 11753055
Crit Care. 2014 Dec 04;18(6):658
pubmed: 25475522
Crit Care Nurs Q. 2013 Jan-Mar;36(1):56-62
pubmed: 23221442
Scand J Med Sci Sports. 2015 Dec;25 Suppl 3:1-72
pubmed: 26606383
Burns. 2018 Nov;44(7):1617-1706
pubmed: 30343831
Shock. 2015 Nov;44(5):397-401
pubmed: 26263438
BMJ Open Sport Exerc Med. 2017 Mar 1;2(1):e000143
pubmed: 28879026

Auteurs

David R Schieffelers (DR)

Multidisciplinary Metabolic Research Unit (M2RUN), MOVANT Research Group, Department of Rehabilitation Sciences and Physiotherapy, Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1, 2610, Wilrijk, Antwerp, Belgium.

Eric van Breda (E)

Multidisciplinary Metabolic Research Unit (M2RUN), MOVANT Research Group, Department of Rehabilitation Sciences and Physiotherapy, Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1, 2610, Wilrijk, Antwerp, Belgium.

Nick Gebruers (N)

Multidisciplinary Metabolic Research Unit (M2RUN), MOVANT Research Group, Department of Rehabilitation Sciences and Physiotherapy, Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1, 2610, Wilrijk, Antwerp, Belgium.
Multidisciplinary Edema Clinic, Antwerp University Hospital, Wilrijkstraat 10, 2650, Edegem, Antwerp, Belgium.

Jill Meirte (J)

Multidisciplinary Metabolic Research Unit (M2RUN), MOVANT Research Group, Department of Rehabilitation Sciences and Physiotherapy, Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1, 2610, Wilrijk, Antwerp, Belgium.
OSCARE, Organisation for burns, scar after-care and research, Van Roiestraat 18, 2170 Merksem, Antwerp, Belgium.

Ulrike Van Daele (U)

Multidisciplinary Metabolic Research Unit (M2RUN), MOVANT Research Group, Department of Rehabilitation Sciences and Physiotherapy, Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1, 2610, Wilrijk, Antwerp, Belgium.
OSCARE, Organisation for burns, scar after-care and research, Van Roiestraat 18, 2170 Merksem, Antwerp, Belgium.

Classifications MeSH